EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem

Royal Marsden NHS Foundation Trust

Status: Enrolling

Conditions: Head and Neck Cancer

Treatments: Other: No intervention.

Study type: Observational

Funder types: Other

Identifiers

NCT05909020

CCR5683

Details and patient eligibility

About

Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway?

Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.

Full description

The EVEREST-HN pathway should be based on a comprehensive understanding of existing HNC diagnostic pathways and what patients and clinicians value in these. The language used within the EVEREST pathway needs to be accessible and optimal to elicit appropriate information.

Enrollment: 165 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients:

• Adults ≥ 18 years referred via suspected HNC pathway without previous history of HNC
• Participants willing and able to give informed consent for participation in the study.

Clinicians:

• Staff at participating sites involved in the diagnostic pathway for people with suspected HNC.

Exclusion criteria

• Individuals who do not meet the inclusion criteria.

Trial design

165 participants in 2 patient groups

Patients

Description:

Approximately 150 adults referred for suspected HNC will be recruited.

Treatment:

Other: No intervention.

Staff

Description:

Approximately 15 ENT and Maxillofacial) clinicians will be recruited.

Treatment:

Other: No intervention.